Last update 07 Dec 2024
HYP-6589
Last update 07 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HYP-6589 |
Target |
Mechanism SOS1 inhibitors(Son of sevenless homolog 1 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HYP-6589A Phase I/II , Open-label, Multi-center, Multi-cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HYP-6589 Monotherapy in Advanced Solid Tumors and Combination With Tyrosine Kinase Inhibitors in Patients With Advanced NSCLC With Target-driven Gene Positivity
一项评估HYP-6589单药治疗晚期实体瘤以及联合酪氨酸激酶抑制剂治疗靶点驱动基因阳性的晚期NSCLC患者的安全性、耐受性、药代动力学和有效性的开放性、多中心、多队列的I/II期研究
[Translation] An open-label, multicenter, multi-cohort Phase I/II study evaluating the safety, tolerability, pharmacokinetics, and efficacy of HYP-6589 as a monotherapy in patients with advanced solid tumors and in combination with tyrosine kinase inhibitors in patients with advanced NSCLC who are positive for target driver genes
100 Clinical Results associated with HYP-6589
Login to view more data
100 Translational Medicine associated with HYP-6589
Login to view more data
100 Patents (Medical) associated with HYP-6589
Login to view more data
100 Deals associated with HYP-6589
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | CN | 27 Nov 2024 | |
| Non-Small Cell Lung Cancer | Phase 2 | CN | 27 Nov 2024 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 1 | CN | 15 Nov 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free